fda drug safety communication semaglutide naion 2025 A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, fda drug safety communication naion

If your trip is longer than 2-3 weeks, you may need to coordinate with your pharmacy for a fresh vial at your destination, or ensure your travel cooling solution can maintain appropriate temperatures for the full duration

Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts

To mitigate this, we suggest not lying down immediately after eating and waiting a few hours before going to bed

How to preserve muscle while losing weight on GLP-1 One concern with any significant weight loss is losing muscle00272-9/abstract) along with fat

The basic eligibility criteria include being 18 years or older and having a BMI of 27 or higher